Diagnostic pathways in breast oncology have moved beyond traditional screening toward personalized, multi-modal approaches. By integrating genomic profiling with advanced imaging, clinicians can now identify specific subtypes of cancer more effectively, leading to tailored treatment plans that improve survival rates and minimize unnecessary invasive procedures. https://www.databridgemarketresearch.com/nucleus/global-breast-cancer-diagnostics-market